Curevo is a biotechnology company focused on developing vaccines with improved tolerability and accessibility, currently advancing a shingles vaccine called amezosvatein.

Vivace Therapeutics is a company that develops small molecule drugs, focusing on a novel cancer therapeutic targeting the Hippo pathway for treating mesothelioma.

Bambusa Therapeutics is a biotechnology company developing transformative treatments for inflammatory and immunological conditions.

Abcuro, Inc. is a biotechnology company developing therapies for autoimmune diseases and cancer, with a focus on their lead candidate, ulviprubart, a monoclonal antibody for treating inclusion body myositis.

Be Biopharma is developing engineered B cell medicines to produce therapeutic proteins for treating conditions like Hemophilia B and Hypophosphatasia.

Verdiva Bio is a clinical-stage biopharmaceutical company developing next-generation oral and injectable treatments for obesity and cardiometabolic disorders.

Indapta Therapeutics develops allogeneic Natural Killer (NK) cell therapies for treating cancer and autoimmune diseases.

Adcendo is a biotech company focused on developing antibody-drug conjugates for treating cancers with high unmet needs.

Synapticure is a virtual care company that provides comprehensive care for neurodegenerative diseases like Alzheimer's, Parkinson's, and ALS across the United States.

Metsera is a clinical-stage biopharmaceutical company developing next-generation treatments for obesity and metabolic diseases using their innovative platforms and Nutrient-Stimulated Hormone analog peptides.

Alentis Therapeutics is a biotech company developing antibody-drug conjugates for treating Claudin-1 positive tumors and organ fibrosis.

Trace Neuroscience is a biopharmaceutical company developing genomic therapies for neurodegenerative diseases, with a focus on treating amyotrophic lateral sclerosis (ALS) by restoring the UNC13A protein.

Evommune, Inc. is a biotechnology company focused on developing treatments for chronic inflammatory diseases.

Alpha-9 Oncology Inc. develops targeted radiopharmaceuticals to improve cancer treatment.

Be Biopharma is developing engineered B cell medicines to produce therapeutic proteins for treating conditions like Hemophilia B and Hypophosphatasia.

Aktis Oncology is a clinical-stage biotechnology company developing a proprietary radiopharmaceutical pipeline, including Nectin-4-targeted miniprotein radioconjugates, for cancer treatment.

Navigator Medicines develops biologics for targeted immune regulation and restoration, focusing on OX40L-targeted mono- and bispecific antibodies.

AM Batteries specializes in advanced lithium-ion dry-electrode technology for more energy-efficient and environmentally friendly battery manufacturing, aiming to reduce energy consumption, capital expenditures, and carbon footprint in the battery production process.

Nature's Toolbox, Inc. (NTx) develops next-generation biomanufacturing platforms for manufacturing mRNA vaccines and protein therapeutics.

Forward Therapeutics is a company focused on advancing the development of next-generation small molecule immune therapies.

Aiolos Bio is a clinical-stage biopharmaceutical company focused on respiratory and inflammatory conditions, with a lead drug candidate, AIO-001, that is a potentially best-in-class TSLP antibody dosed every 6 months.

Rampart Bioscience is a biotechnology company developing next-generation biologics using their proprietary DNA-based medicines platform, HALO, with a focus on treating hypophosphatasia.

Ventricle Health is a virtual cardiology care network that offers virtual therapy, remote patient monitoring, and patient education and advocacy, with plans to expand its heart failure management therapeutic model in collaboration with value-based care provider groups and payers.

Commons Clinic is a Los Angeles-based health system specializing in spine, orthopedics, and pain management, offering comprehensive care programs and a network of physicians, care centers, surgical facilities, and a virtual clinic.

Adela is a healthcare technology company that specializes in blood testing for early cancer detection and minimal residual disease monitoring using a genome-wide methylome enrichment platform.

Vaxess Technologies is a life sciences company that is developing a sustained release patch technology for the stable, refrigeration-free administration of vaccines and therapeutics, with a current focus on mRNA vaccines.

Mariana Oncology is a biotechnology company that develops targeted peptide-based radiopharmaceuticals for the treatment of cancer, with a focus on delivering optimized radiation doses to solid tumors.

Nimbus Therapeutics is a clinical-stage company that uses computational chemistry and structure-based drug design to develop novel therapies for immunology, cancer, and metabolic diseases.

Star Therapeutics is a biotechnology company that develops first-in-class antibody therapies, primarily for hematology and immunology, and also generates additional biotech companies focused on discovering and advancing novel antibody therapies.

Superluminal Medicines is a generative biology and chemistry company that uses machine learning and big data to advance small molecule drug discovery programs, with a focus on high-value G protein-coupled receptor (GPCR) targets.

Sortera Technologies is a material sorting company that uses artificial intelligence data analytics to sort pre-production aluminum and end-of-life mixed metals, enabling the use of recycled material in manufacturing, reducing costs and pollution, and increasing availability for domestic manufacturers.

ExcepGen is a genetic medicine startup that develops technology to enhance the effectiveness and tolerability of nucleic acid therapeutics, potentially expanding the reach of DNA-based and RNA-based genetic medicines.